Symptomatic Necrosis With Antibody-Drug Conjugates and Concurrent Stereotactic Radiotherapy for Brain Metastases
Emily S. Lebow, Luke Pike, Andrew D. Seidman, Nelson S. Moss, Kathryn Beal, Yao Yu
Abstract
This cohort study investigates whether brain metastases that manifest after stereotactic radiotherapy with concurrent antibody-drug conjugates are associated with an increased risk of symptomatic radiation necrosis.
Topics & Concepts
MedicineRadiation therapyDrugStereotactic radiotherapyOncologyNecrosisRadiosurgeryAntibody-drug conjugateAntibodyInternal medicinePharmacologyMonoclonal antibodyImmunologyBrain Metastases and TreatmentRadiopharmaceutical Chemistry and ApplicationsLung Cancer Treatments and Mutations